What is Ora?
Ora operates as a dedicated full-service ophthalmic clinical research and product development firm, exclusively focused on ophthalmology. Boasting over 45 years of industry experience, the company has a proven track record, having successfully managed more than 3,000 ophthalmic clinical projects. This extensive expertise has been instrumental in facilitating the market approval of over 85 drugs and devices, positioning Ora as a critical partner for innovation in eye care.
How much funding has Ora raised?
Ora has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Ora
PPP
Public-Private Partnership
What's next for Ora?
The recent major strategic investment signals Ora's robust position and future expansion capabilities. As a company with a long history of facilitating market approvals, this capital infusion is likely to accelerate its product development pipeline and broaden its research services. The enterprise-level funding context suggests Ora is poised for further scaling, potentially through enhanced technological adoption, expanded clinical trial capacity, or strategic partnerships aimed at addressing unmet needs in ophthalmic treatments and devices. This strategic backing will enable Ora to maintain its leadership in a highly specialized and critical segment of the healthcare industry.
See full Ora company page
